Inventum.AI

Startup

Inventum.AI represents a significant advancement in the discovery of new therapeutics, promising to enhance the efficiency and effectiveness of pharmaceutical research. By leveraging the combined strengths of its expert team and cutting-edge AI technology, the platform not only increases the accuracy of drug molecule design but also democratizes access to drug discovery. This opens the door for more organizations to participate in the development of novel treatments. Our mission is to develop novel molecules using end-to-end generative AI with a focus on protein-ligand interactions. These molecules will meet the criteria of medicinal chemists, with a high probability of passing clinical trials, ensuring maximum efficacy and safety for patients.